Sort   by:  
 Page size 
Pancreatic diseases including diabetes and exocrine insufficiency would benefit from therapies that reverse cellular loss and/or restore cellular mass. The identification of molecular pathways that influence cellular growth is therefore critical for future therapeutic generation. Deoxyhypusine synth...
ORGANISM(S): Mus Musculus (ncbitaxon:10090) 
2025-10-30 | MSV000099697 | MassIVE
As professional secretory cells, beta cells require adaptable mRNA translation to facilitate a rapid synthesis of proteins, including insulin, in response to changing metabolic cues. Specialized mRNA translation programs are essential drivers of cellular development and differentiation. However, in ...
ORGANISM(S): Mus Musculus (ncbitaxon:10090) 
2023-10-12 | MSV000093089 | MassIVE
Analysis .bam files from HiSeq sequencing of Australian ICGC PDAC study samples, submitted 20130826
Sequencing data for Australian Pancreatic Cancer study submitted 20130102
BAM outputs from RSEM (https://deweylab.github.io/RSEM/) analysis of RNASeq sequencing on HiSeq platform of tumour samples from 95 pancreatic adenocarcinoma cases.
OICR PANCREATIC CANCER DATASET
Sequencing data for PDAC cell lines generated by QCMG
Additional sequencing data for 173 donors in EGAS00001000154, a study of Pancreatic Ductal Adenocarcinoma. WGS libraries were used for high-cellularity cases, WXS sequencing to high depth on low-cellularity cases. HiSeq 2xxx platform was used in all cases. The analysis files associated with this dat...
Pancreatic adenocarcinoma QCMG 20120201
Sort   by:  
 Page size